Visible Genetics Gearing Up For TruGene HIV-1 Genotyping Kit Roll-Out
This article was originally published in The Gray Sheet
Executive Summary
Visible Genetics has locked up 25% of the U.S. HIV genotyping market with its TruGene HIV-1 genotyping kit, company officials remarked during a Feb. 24 teleconference.